Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

TPEX:4186 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	716	1,004	1,418	1,485	1,593	1,674
Market Cap Growth	-28.38%	-29.21%	-4.54%	-6.78%	-4.84%	-26.63%
Enterprise Value	837	1,145	1,566	1,648	1,716	1,780
Last Close Price	7.95	11.15	15.75	16.50	17.70	18.60

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	43.96	35.78	61.97	-	502.52	-
PS Ratio	2.05	2.75	4.00	4.70	5.01	6.88
PB Ratio	2.67	3.52	5.53	6.35	6.51	6.93
P/TBV Ratio	2.67	3.52	5.53	6.35	6.61	7.24
P/FCF Ratio	37.89	50.76	324.59	2226.39	-	-
P/OCF Ratio	13.11	18.89	170.23	117.78	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	2.40	3.14	4.42	5.22	5.39	7.31
EV/EBITDA Ratio	18.13	22.15	26.14	66.04	55.41	-
EV/EBIT Ratio	31.28	30.63	34.92	386.01	225.46	-
EV/FCF Ratio	44.34	57.91	358.55	2470.58	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	1.04	0.93	0.90	1.31	1.14	1.03
Debt / EBITDA Ratio	6.06	4.63	3.51	10.18	7.81	-
Debt / FCF Ratio	14.81	13.36	52.59	460.63	-	-
Net Debt / Equity Ratio	0.45	0.43	0.48	0.54	0.50	0.37
Net Debt / EBITDA Ratio	2.98	2.39	2.06	5.01	3.91	-1.15
Net Debt / FCF Ratio	6.45	6.24	28.24	187.56	-4.35	-1.41
Asset Turnover	0.48	0.51	0.50	0.43	0.45	0.32
Inventory Turnover	6.27	6.29	5.53	5.27	5.29	4.83
Quick Ratio	0.88	0.88	0.85	0.74	0.91	0.93
Current Ratio	0.98	0.98	0.96	0.82	1.07	1.09
Return on Equity (ROE)	6.05%	10.36%	9.33%	-4.46%	1.30%	-39.48%
Return on Assets (ROA)	2.32%	3.28%	3.93%	0.37%	0.67%	-8.36%
Return on Invested Capital (ROIC)	6.86%	9.49%	12.14%	1.18%	1.88%	-28.58%
Return on Capital Employed (ROCE)	5.70%	7.90%	10.20%	1.00%	1.60%	-21.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.20%	2.79%	1.61%	-0.72%	0.20%	-7.08%
FCF Yield	2.64%	1.97%	0.31%	0.04%	-1.75%	-3.78%
Buyback Yield / Dilution	7.83%	-	-	-	-	-11.05%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error